Celestone Soluspan: Affected lots may contain the presence of foreign matter.
Last updated
Summary
Product
Celestone Soluspan
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lots |
|---|---|---|---|---|---|
Celestone Soluspan |
Celestone Soluspan |
DIN 00028096 |
Suspension for injection |
Betamethasone (Betamethasone Sodium Phosphate) 3 MG / ML, |
U032954, |
Issue
Affected lots may contain the presence of foreign matter.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Healthcare Establishments, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Organon Canada Inc.
16766 Route Transcanadienne
Kirkland, Quebec
H9H 4M7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-72631
Get notified
Receive notifications for new and updated recalls and alerts by category.